Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics to Seek BRCA CDx Approval From Japanese Regulators

NEW YORK (GenomeWeb) – Myriad Genetics said today that it will submit its BRACAnalysis CDx to Japan's Pharmaceuticals and Medical Devices Agency for regulatory approval, alongside AstraZeneca's PARP inhibitor Lynparza (olaparib).

In December 2014, the US Food and Drug Administration approved BRACAnalysis CDx as a test for identifying advanced ovarian cancer patients previously treated with three or more lines of chemotherapy, who harbor mutations in BRCA1 and BRCA2 genes and therefore might benefit from treatment with Lynparza.

Earlier this year, the FDA also granted fast track designation to Lynparza as a treatment for BRCA-mutated, platinum-sensitive, relapsed ovarian cancer. AstraZeneca recently announced that the Phase III SOLO-2 trial had shown that this subset of ovarian cancer patients experienced statistically-significant improvement in progression-free survival when they received Lynparza as a second-line maintenance treatment compared to those who received placebo. The drugmaker is planning to announce full results from SOLO-2 at an upcoming medical meeting.

At a Drug Information Association meeting a year ago, the companies provided a look at their development process for the companion diagnostic, noting that the process of getting it approved could provide a blueprint for other companies looking to take laboratory-developed tests through the FDA.

In June, AstraZeneca also announced a partnership with Foundation Medicine to develop a next-generation sequencing based CDx as part of its global development program for Lynparza.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.